Metoprolol Succinate (25 mg) PR + Amlodipine (2.5 mg) is a synergistic combination therapy used for the effective management of hypertension and cardiovascular conditions. Metoprolol, a beta-1 selective blocker, reduces heart rate and myocardial oxygen demand, while Amlodipine, a calcium channel blocker, relaxes vascular smooth muscles and improves blood flow. Together, they provide sustained blood pressure control, reduce cardiac workload, and help in preventing complications such as angina and heart-related events. The prolonged-release formulation ensures consistent therapeutic levels throughout the day.
